What is 006280.KS's current stock price?

006280.KS (GC Biopharma Corp.) is currently trading at ₩129,900.00 with a market cap of ₩1.52T.

What sector is GC Biopharma Corp. in?

GC Biopharma Corp. (006280.KS) operates in the Healthcare sector, specifically in the Medical - Pharmaceuticals industry.

InvestLog

Back to Market返回行情

006280.KS GC Biopharma Corp.

KSCHealthcare

₩129,900+2.69%LatestMarket Cap: ₩1.52T

As of 2026-08-09 03:21

Why 006280.KS matters now

GC Biopharma Corp. (006280.KS) is a Korea stock in Healthcare. The latest InvestLog snapshot shows ₩129,900.00 with +2.69% on the session and ₩1.52T in market capitalization.

Valuation context is available even where detailed statement rows are sparse: InvestLog currently shows P/E -29.69, gross margin 19.7%, and operating margin 2.4%.

Valuation

P/E (TTM)

-29.69

PEG

—

P/B

0.68

P/S

0.75

EV/EBITDA

19.62

DCF Value

—

FCF Yield

3.4%

Div Yield

1.2%

Margins & Returns

Gross Margin

19.7%

Operating Margin

2.4%

Net Margin

-2.6%

ROE

-4.0%

ROA

-1.8%

ROIC

2.0%

Listing Info

Market

Korea

Exchange

KSC

Currency

KRW

Sector

Healthcare

Industry

Medical - Pharmaceuticals

Country

GC Biopharma Corp. is a pharmaceutical enterprise primarily involved in the production and distribution of various medical products. Its extensive portfolio encompasses specialized treatments for blood-related conditions, non-prescription remedies, general medications, and immunizations, among other therapeutic solutions. The company was established on November 1, 1969, and its principal corporate offices are situated in Yongin, South Korea.